More than 100,000 Canadians are affected by Parkinson’s disease which affects the brain. It can disrupt the daily lives of patients as they find it challenging to walk, talk and express themselves. Current therapies to treat Parkinson’s disease provide symptomatic relief and are not effective. A protein called alpha synuclein is known to promote brain […]
Read More